Cargando…
Biochip-Based Detection of KRAS Mutation in Non-Small Cell Lung Cancer
This study is aimed at evaluating the potential of a biochip assay to sensitively detect KRAS mutation in DNA from non-small cell lung cancer (NSCLC) tissue samples. The assay covers 10 mutations in codons 12 and 13 of the KRAS gene, and is based on mutant-enriched PCR followed by reverse-hybridizat...
Autores principales: | Kriegshäuser, Gernot, Fabjani, Gerhild, Ziegler, Barbara, Zöchbauer-Müller, Sabine, End, Adelheid, Zeillinger, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257086/ https://www.ncbi.nlm.nih.gov/pubmed/22272089 http://dx.doi.org/10.3390/ijms12128530 |
Ejemplares similares
-
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
por: Auner, Veronika, et al.
Publicado: (2009) -
Duplex Reverse-Hybridization Assay for The Simultaneous Detection of KRAS/BRAF Mutations in FFPE-extracted Genomic DNA from Colorectal Cancer Specimens
por: Buxhofer-Ausch, Veronika, et al.
Publicado: (2013) -
DNA methylation of microRNA‐coding genes in non‐small‐cell lung cancer patients
por: Heller, Gerwin, et al.
Publicado: (2018) -
SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
por: Altenberger, Corinna, et al.
Publicado: (2017) -
DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers
por: Heller, Gerwin, et al.
Publicado: (2014)